感情 发表于 2025-3-23 10:04:42

Submitted on: 09 September 2006.
Revised on: 23 December 2006.
Accepted on: 09 January 2007.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

光亮 发表于 2025-3-23 16:41:47

http://reply.papertrans.cn/2/158/15710/15710-12.png

harbinger 发表于 2025-3-23 20:17:34

Submitted on: 28 September 2011.
Revised on: 30 December 2011.
Accepted on: 24 January 2012.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

极为愤怒 发表于 2025-3-23 22:28:04

Submitted on: 10 January 2012.
Revised on: 29 March 2012.
Accepted on: 21 May 2012.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

hazard 发表于 2025-3-24 03:00:42

Submitted on: 28 May 2012.
Revised on: 05 August 2012.
Accepted on: 08 September 2012.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Budget 发表于 2025-3-24 06:51:08

Submitted on: 29 June 2009.
Revised on: 24 October 2009.
Accepted on: 13 December 2009.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

傻 发表于 2025-3-24 12:14:17

Submitted on: 01 October 2010.
Revised on: 20 November 2010.
Accepted on: 04 January 2011.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

nephritis 发表于 2025-3-24 15:20:55

http://reply.papertrans.cn/2/158/15710/15710-18.png

具体 发表于 2025-3-24 20:48:31

http://reply.papertrans.cn/2/158/15710/15710-19.png

滔滔不绝地讲 发表于 2025-3-24 23:12:07

http://reply.papertrans.cn/2/158/15710/15710-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 2024/2025影响因子:2.673 (J CARDIOVASC PHARM) (0160-2446). (CARDIAC & CARDIOVAS